BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3361655)

  • 1. Hydration properties of urinary compounds obtained from normal and stone former individuals. An NMR study.
    Azoury R; Weininger J; Iaina A; Abrashkin S
    J Urol; 1988 May; 139(5):1111-4. PubMed ID: 3361655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydration feature of urinary compounds. Evidence for molecular abnormality in calcium oxalate urolithiasis.
    Azoury R; Ramon J; Abrashkin S; Shalev J; Goldwasser B
    Urol Res; 1990; 18(1):7-11. PubMed ID: 2316076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton MR properties of lyophilized urine samples from normal and stone former individuals.
    Azoury R; Abrashkin S; Weininger J; Iaina A
    Magn Reson Imaging; 1988; 6(1):49-52. PubMed ID: 3352480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaluria--the neglected stepchild of nephrolithiasis?
    Preminger GM
    J Urol; 2003 Aug; 170(2 Pt 1):402-3. PubMed ID: 12853785
    [No Abstract]   [Full Text] [Related]  

  • 5. Supersaturated urine.
    Lancet; 1979 Jun; 1(8128):1219-20. PubMed ID: 87681
    [No Abstract]   [Full Text] [Related]  

  • 6. Do indomethacin, thiazide, pyridoxine or allopurinol prevent calcium oxalate stones?
    Reis-Santos JM; Guimarães P; Correia R; Ferreira AM
    Contrib Nephrol; 1987; 58():176-80. PubMed ID: 3691121
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M; Yendt ER
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazide does not affect urine oxalate excretion.
    Parks JH; Coe FL
    J Urol; 2003 Aug; 170(2 Pt 1):393-6. PubMed ID: 12853783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high molecular weight urinary macromolecules on crystallization of calcium oxalate dihydrate.
    Drach GW; Kraljevich Z; Randolph AD
    J Urol; 1982 Apr; 127(4):805-10. PubMed ID: 7069862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary calculi.
    Gambaro G; Baggio B
    J Urol; 1987 Feb; 137(2):318-9. PubMed ID: 3806837
    [No Abstract]   [Full Text] [Related]  

  • 13. A thermodynamic equilibrium model for calcium salt urolithiasis: clinical application.
    Ashby R; Györy AZ
    Exp Nephrol; 1997; 5(3):246-52. PubMed ID: 9208285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of recurrent urinary calcium calculi].
    Ookawa J
    Nihon Hinyokika Gakkai Zasshi; 1986 Dec; 77(12):1947-9. PubMed ID: 3586448
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of long-term thiazide therapy on calcium and phosphate metabolism in patients with hypercalciuria].
    Kawamura J; Okada Y; Yoshida O; Shigeno C; Morita R; Torizuka K
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):921-8. PubMed ID: 7176187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.